Paulina M. Wojnarowicz
0000-0002-0185-6367
Publication & Citation Trends
Publications
0 total
Abstract 6231: Activation of GCN2 by HC-7366 results in significant antitumor efficacy as monotherapy and in combination with multiple standard of care agents in various solid cancer models
Cited by 3
Semantic Scholar
Abstract A30: Activation of GCN2 by HC-7366 results in significant anti-tumor efficacy as monotherapy and in combination with Venetoclax in AML models
Cited by 0
Semantic Scholar
Anti-tumor effects of an ID antagonist with no observed acquired resistance OA
Cited by 20
Semantic Scholar
Anti-tumor effects of an Id antagonist with no acquired resistance OA
Cited by 4
Semantic Scholar
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization OA
Cited by 41
Semantic Scholar
Abstract 4975: A small molecule pan Id protein antagonist shows strong antitumor activity
Cited by 0
Semantic Scholar
HPMA–Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer OA
Cited by 21
Semantic Scholar
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients OA
Cited by 37
Semantic Scholar
Research Topics
Cancer, Hypoxia, and Metabolism
(18)
Immune cells in cancer
(16)
Nanoparticle-Based Drug Delivery
(13)
Microtubule and mitosis dynamics
(13)
Melanoma and MAPK Pathways
(12)
Affiliations
Memorial Sloan Kettering Cancer Center
Montreal General Hospital
Kettering University
Minneapolis Business College
FuelCell Energy (United States)